Bridging Chemical and Biological Data: Implications for Pharmaceutical Drug Discovery

Computational Approaches in Cheminformatics and Bioinformatics

Volumn , Issue , 2011, Pages 25-56

  Jenkins, Jeremy L ^b   Scheiber, Josef ^b,c   Mikhailov, Dmitri ^b   Bender, Andreas ^a   Schuffenhauer, Ansgar ^d   Cornett, Ben ^b   Chan, Vivien ^b   Kondracki, Jason ^b   Rohde, Bernhard ^d   Davies, John W ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c ROCHE DIAGNOSTICS GMBH   (Germany)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Biocuration in biomedical research; Chemogenomics knowledge, lead finding; Pharmaceutical drugs, integrated data

Indexed keywords

EID: 84886000909     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118131411.ch2     Document Type: Chapter

References (52)

1. Koniger, P.; Janowitz, K. Drowning in information, but thirsty for knowledge. Int. J. Inf. Manage. 1995, 15, 5-16.
2. Bender, A.; Bojanic, D.; Davies, J. W.; Crisman, T. J.; Mikhailov, D.; Scheiber, J.; Jenkins, J. L.; Deng, Z.; Hill, W. A.; Popov, M.; Jacoby, E.; Glick, M. Which aspects of HTS are empirically correlated with downstream success? Curr. Opin. Drug Discov. Dev. 2008, 11(3), 327-337.
3. Zimmer, C. Evolution: The Triumph of an Idea. Harper Perennial, New York, 2002.
4. Torr-Brown, S. Advances in knowledge management for pharmaceutical research and development. Curr. Opin. Drug Discov. Dev. 2005, 8(3), 316-322.
5. Pisano, G. P. Can science be a business? Lessons from Biotech. Harvard Bus. Rev. 2006, Oct.
6. Bergman, M. K. Climbing the Data Federation Pyramid. http://www .mkbergman.com [internet blog], 2006, p. 229.
7. Slater, T.; Bouton, C.; Huang, E. S. Beyond data integration. Drug Discov. Today 2008, 13(13-14), 584-589.
8. Bender, A.; Scheiber, J.; Glick, M.; Davies, J. W.; Azzaoui, K.; Hamon, J.; Urban, L.; Whitebread, S.; Jenkins, J. L. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure. ChemMedChem. 2007, 2(6), 861-873.
9. Schuffenhauer, A.; Zimmermann, J.; Stoop, R.; van der Vyver, J. J.; Lecchini, S.; Jacoby, E. An ontology for pharmaceutical ligands and its application for in silico screening and library design. J. Chem. Inf. Comput. Sci . 2002, 42(4), 947-955.
10. Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S. The protein kinase complement of the human genome. Science 2002, 298(5600), 1912-1934.
11. Webb, E. C. Enzyme Nomenclature: Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes. Academic Press, New York, 1992.
12. Smith, B.; Ashburner, M.; Rosse, C.; Bard, J.; Bug, W.; Ceusters, W.; Goldberg, L. J.; Eilbeck, K.; Ireland, A.; Mungall, C. J.; et al. The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nat. Biotechnol. 2007, 25(11), 1251-1255.
13. Rubin, D. L.; Lewis, S. E.; Mungall, C. J.; Misra, S.; Westerfield, M.; Ashburner, M.; Sim, I.; Chute, C. G.; Solbrig, H.; Storey, M. A.; et al. National Center for Biomedical Ontology: advancing biomedicine through structured organization of scientific knowledge. OMICS 2006, 10(2), 185-198.
14. Degtyarenko, K.; de Matos, P.; Ennis, M.; Hastings, J.; Zbinden, M.; McNaught, A.; Alcantara, R.; Darsow, M.; Guedj, M.; Ashburner, M. ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 2008, 36(Database issue), D344-D350.
15. Gardner, S. P. Ontologies and semantic data integration. Drug Discov. Today 2005, 10(14), 1001-1007.
16. Taylor, C. F.; Field, D.; Sansone, S. A.; Aerts, J.; Apweiler, R.; Ashburner, M.; Ball, C. A.; Binz, P. A.; Bogue, M.; Booth, T.; et al. Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project. Nat. Biotechnol. 2008, 26(8), 889-896.
17. Howe, D.; Costanzo, M.; Fey, P.; Gojobori, T.; Hannick, L.; Hide, W.; Hill, D. P.; Kania, R.; Schaeffer, M.; St Pierre, S; Twigger, S; White, O; Rhee, S.Y. Big data: the future of biocuration. Nature 2008, 455(7209), 47-50.
18. Williams, A. J. Public chemical compound databases. Curr. Opin. Drug Discov. Dev. 2008, 11(3), 393-404.
19. Williams, A. J. Internet-based tools for communication and collaboration in chemistry. Drug Discov. Today 2008, 13(11-12), 502-506.
20. Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. DrugBank: a knowledge base for drugs, drug actions and drug targets. Nucleic Acids Res. 2008, 36(Database issue), D901-D906.
21. http://www.cbi.or.jp/cbi/DigtalTL/Bioinfo_Universities.html. 2008.
22. Guha, R.; Schurer, S. C. Utilizing high throughput screening data for predictive toxicology models: protocols and application to MLSCN assays. J. Comput. Aided Mol. Des. 2008, 22(6-7), 367-384.
23. http://en.wikipedia.org/wiki/Knowledgebase. 2008.
24. Weininger, D. SMILES, a chemical language and information system: 1. Introduction to methodology and encoding rules. J. Chem. Inf. Comput. Sci . 1988, 28, 31-36.
25. Jenkins, J. L.; Bender, A.; Davies, J. W. In silico target fishing: predicting biological targets from chemical structure. Drug Discov. Today: Technol. 2008, 3, 413-421.
26. Bender, A.; Mussa, H. Y.; Glen, R. C. Screening for dihydrofolate reductase inhibitors using MOLPRINT 2D, a fast fragment-based method employing the naive Bayesian classifier: limitations of the descriptor and the importance of balanced chemistry in training and test sets. J. Biomol. Screen. 2005, 10(7), 658-666.
27. Bemis, G. W.; Murcko, M. A. The properties of known drugs: 1. Molecular frameworks. J. Med. Chem. 1999, 39, 2887-2893.
28. Keiser, M. J.; Roth, B. L.; Armbruster, B. N.; Ernsberger, P.; Irwin, J. J.; Shoichet, B. K. Relating protein pharmacology by ligand chemistry. Nat. Biotechnol. 2007, 25(2), 197-206.
29. Hert, J.; Keiser, M. J.; Irwin, J. J.; Oprea, T. I.; Shoichet, B. K. Quantifying the relationships among drug classes. J. Chem. Inf. Model. 2008, 48(4), 755-765.
30. Paolini, G. V.; Shapland, R. H.; van Hoorn, W. P.; Mason, J. S.; Hopkins, A. L. Global mapping of pharmacological space. Nat. Biotechnol. 2006, 24(7), 805-815.
31. Nidhi; Glick, M.; Davies, J. W.; Jenkins, J. L. Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases. J. Chem. Inf. Model. 2006, 46(3), 1124-1133.
32. Young, D. W.; Bender, A.; Hoyt, J.; McWhinnie, E.; Chirn, G. W.; Tao, C. Y.; Tallarico, J. A.; Labow, M.; Jenkins, J. L.; Mitchison, T. J.; Feng, Y. Integrating high-content screening and ligand-target prediction to identify mechanism of action. Nat. Chem. Biol. 2008, 4(1), 59-68.
33. Plouffe, D.; Brinker, A.; McNamara, C.; Henson, K.; Kato, N.; Kuhen, K.; Nagle, A.; Adrian, F.; Matzen, J. T.; Anderson, P.; et al. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc. Natl. Acad. Sci. USA 2008, 105(26), 9059-9064.
34. Zhou, Y.; Zhou, B.; Chen, K.; Yan, S. F.; King, F. J.; Jiang, S.; Winzeler, E. A. Large-scale annotation of small-molecule libraries using public databases. J. Chem. Inf. Model. 2007, 47(4), 1386-1394.
35. May, M. Working out the flow. Bio-IT World, September 18, 2006. Cambridge Healthtech Institute, Needham, MA USA.
36. Southan, C.; Varkonyi, P.; Muresan, S. Complementarity between public and commercial databases: new opportunities in medicinal chemistry informatics. Curr. Top. Med. Chem. 2007, 7(15), 1502-1508.
37. Sutherland, J. J.; Higgs, R. E.; Watson, I.; Vieth, M. Chemical fragments as foundations for understanding target space and activity prediction. J. Med. Chem. 2008, 51(9), 2689-2700.
38. Vieth, M.; Higgs, R. E.; Robertson, D. H.; Shapiro, M.; Gragg, E. A.; Hemmerle, H. Kinomics: structural biology and chemogenomics of kinase inhibitors and targets. Biochim. Biophys. Acta 2004, 1697(1-2), 243-257.
39. Feigenbaum, L.; Herman, I.; Hongsermeier, T.; Neumann, E.; Stephens, S. The Semantic Web in action. Sci. Am. 2007, 297(6), 64-71.
40. Agrafiotis, D. K.; Alex, S.; Dai, H.; Derkinderen, A.; Farnum, M.; Gates, P.; Izrailev, S.; Jaeger, E. P.; Konstant, P.; Leung, A.; et al. Advanced biological and chemical discovery (ABCD): centralizing discovery knowledge in an inherently decentralized world. J. Chem. Inf. Model. 2007, 47(6), 1999-2014.
41. Ficenec, D.; Osborne, M.; Pradines, J.; Richards, D.; Felciano, R.; Cho, R. J.; Chen, R. O.; Liefeld, T.; Owen, J.; Ruttenberg, A.; et al. Computational knowledge integration in biopharmaceutical research. Brief. Bioinf . 2003, 4(3), 260-278.
42. Ertl, P.; Seltzer, P.; Muhlbacher, J. Web-based cheminformatics tools deployed via corporate intranets. Drug Discov. Today: Biosilico 2004, 2(5), 201-207.
43. Searls, D. B. Data integration: challenges for drug discovery. Nat. Rev. Drug Discov. 2005, 4(1), 45-58.
44. Jacoby, E.; Schuffenhauer, A.; Floersheim, P. Chemogenomics knowledgebased strategies in drug discovery. Drug News Perspect. 2003, 16(2), 93-102.
45. Maggiora, G. M.; Johnson, M. A. Concepts and Applications of Molecular Similarity. Wiley, New York, 1990.
46. Kuhn, M.; Campillos, M.; Gonzalez, P.; Jensen, L. J.; Bork, P. Largescale prediction of drug-target relationships. FEBS Lett. 2008, 582(8), 1283-1290.
47. Schuffenhauer, A.; Floersheim, P.; Acklin, P.; Jacoby, E. Similarity metrics for ligands reflecting the similarity of the target proteins. J. Chem. Inf. Comput. Sci . 2003, 43(2), 391-405.
48. West-Eberhard, M. Developmental Plasticity and Evolution. Oxford University Press, New York, 2006.
49. Bantscheff, M.; Eberhard, D.; Abraham, Y.; Bastuck, S.; Boesche, M.; Hobson, S.; Mathieson, T.; Perrin, J.; Raida, M.; Rau, C.; et al. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat. Biotechnol. 2007, 25(9), 1035-1044.
50. http://www.ncgc.nih.gov/guidance/manual_toc. html. 2008.
51. Tapscott, D.; Williams, A. D. Wikinomics: How Mass Collaboration Changes Everything. Portfolio, New York, 2006.
52. Waldrop, M. Big data: Wikiomics. Nature 2008, 455(7209), 22-25.